Literature DB >> 25081716

High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis.

Suyanee Thongchot1, Puangrat Yongvanit, Watcharin Loilome, Wanchana Seubwai, Kutcharin Phunicom, Wichittra Tassaneeyakul, Chawalit Pairojkul, Wisuttiphong Promkotra, Anchalee Techasen, Nisana Namwat.   

Abstract

Hypoxia and autophagy are known to facilitate tumor progression. We here aimed to investigate the role of hypoxia-associated autophagy in cholangiocarcinoma (CCA) survival and metastasis. Immunostaining of hypoxic- responsive proteins (HIF-1α and BNIP3) and a key regulator of autophagy (PI3KC3) were examined in CCA tissues and their expression levels were compared with clinicopathological parameters. A hypoxia mimicking condition (CoCl2 treatment) was also tested regarding CCA cell functions. Our results showed that HIF-1α (66%), BNIP3 (44%) and PI3KC3 (46%) showed strong staining in human CCA tissues. Positive expression of HIF-1α (p=0.033), BNIP3 (p=0.040) and PI3KC3 (p=0.037) was significantly correlated with lymph node metastasis. HIF-1α was well associated with BNIP3 (r=0.3, p<0.01) and PI3KC3 (r=0.2, p<0.01). The survival rates of patients who were positive with HIF-1α (p=0.047) or co-expressed HIF-1α and BNIP3 (p=0.032) or HIF-1α and PI3KC3 (p=0.043) were significantly greater than in the negative groups. CCA cells treated with CoCl2 showed an increase in HIF-1α, BNIP3, PI3KC3 and LC3-II, with increased cell migration and pFAK levels. These data suggest that hypoxia associated autophagy enhances CCA metastasis, resulting in a poor prognosis of CCA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25081716     DOI: 10.7314/apjcp.2014.15.14.5873

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  23 in total

1.  Radiation Therapy Reduced Blood Levels of LDH, HIF-1α, and miR-210 in OSCC.

Authors:  Marcela Gonçalves de Souza; Sabrina Ferreira de Jesus; Eloá Mangabeira Santos; Emisael Stenio Batista Gomes; Arlen de Paulo Santiago Filho; Eliane Macedo Sobrinho Santos; Luiz Henrique da Silveira; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; Lucyana Conceição Farias; André Luiz Sena Guimarães
Journal:  Pathol Oncol Res       Date:  2018-11-08       Impact factor: 3.201

2.  GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.

Authors:  Sonia Brun; Firas Bassissi; Cindy Serdjebi; Marie Novello; Jennifer Tracz; François Autelitano; Marie Guillemot; Philippe Fabre; Jérôme Courcambeck; Christelle Ansaldi; Eric Raymond; Philipe Halfon
Journal:  Invest New Drugs       Date:  2019-02-19       Impact factor: 3.850

3.  Liver Tumor Microenvironment.

Authors:  Diamantis I Tsilimigras; Ioannis Ntanasis-Stathopoulos; Dimitrios Moris; Timothy M Pawlik
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma.

Authors:  Kulthida Vaeteewoottacharn; Ryusho Kariya; Paweena Dana; Sawako Fujikawa; Kouki Matsuda; Koichi Ohkuma; Eriko Kudo; Ratthaphol Kraiklang; Chaisiri Wongkham; Sopit Wongkham; Seiji Okada
Journal:  Tumour Biol       Date:  2016-01-13

Review 5.  The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma.

Authors:  Oraianthi Fiste; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Michalis Liontos; Konstantinos Koutsoukos; Meletios Athanasios Dimopoulos; Flora Zagouri
Journal:  Vaccines (Basel)       Date:  2021-04-22

Review 6.  Targeting Lymphangiogenesis and Lymph Node Metastasis in Liver Cancer.

Authors:  Sukanya Roy; Priyanka Banerjee; Burcin Ekser; Kayla Bayless; David Zawieja; Gianfranco Alpini; Shannon S Glaser; Sanjukta Chakraborty
Journal:  Am J Pathol       Date:  2021-09-09       Impact factor: 4.307

Review 7.  The Tumor Microenvironment in Cholangiocarcinoma Progression.

Authors:  Luca Fabris; Keisaku Sato; Gianfranco Alpini; Mario Strazzabosco
Journal:  Hepatology       Date:  2020-11-06       Impact factor: 17.298

8.  Progression of thanatophagy in cadaver brain and heart tissues.

Authors:  Gulnaz T Javan; Insu Kwon; Sheree J Finley; Youngil Lee
Journal:  Biochem Biophys Rep       Date:  2015-11-18

9.  Inhibition of TLR7 and TLR9 Reduces Human Cholangiocarcinoma Cell Proliferation and Tumor Development.

Authors:  Fatma El Zahraa Mohamed; Rajiv Jalan; Shane Minogue; Fausto Andreola; Abeba Habtesion; Andrew Hall; Alison Winstanley; Steven Olde Damink; Massimo Malagó; Nathan Davies; Tu Vinh Luong; Amar Dhillon; Rajeshwar Mookerjee; Dipok Dhar; Rajai Munir Al-Jehani
Journal:  Dig Dis Sci       Date:  2021-05-03       Impact factor: 3.199

Review 10.  Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?

Authors:  Simone Brivio; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  J Clin Med       Date:  2015-12-19       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.